These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11720147)

  • 1. Valproate-induced encephalopathy.
    Chen WT; Yen DJ; Yu HY; Liao KK
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Aug; 64(8):474-8. PubMed ID: 11720147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam.
    Lokrantz CM; Eriksson B; Rosén I; Asztely F
    Acta Neurol Scand; 2004 Apr; 109(4):297-301. PubMed ID: 15016014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Encephalopathies caused by valproate].
    Göbel R; Görtzen A; Bräunig P
    Fortschr Neurol Psychiatr; 1999 Jan; 67(1):7-11. PubMed ID: 10065384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
    Hamer HM; Knake S; Schomburg U; Rosenow F
    Neurology; 2000 Jan; 54(1):230-2. PubMed ID: 10636156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate.
    Finsterer J; Pelzl G; Hess B
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case report of valproate encephalopathy].
    Miyamoto T; Miyamoto M; Hirata K; Katayama S
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalopathy induced by levetiracetam added to valproate.
    Bauer J
    Acta Neurol Scand; 2008 May; 117(5):374-6. PubMed ID: 18081909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate increases the risk of valproic acid-induced encephalopathy.
    Noh Y; Kim DW; Chu K; Lee ST; Jung KH; Moon HJ; Lee SK
    Epilepsia; 2013 Jan; 54(1):e1-4. PubMed ID: 22691153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
    Chopra A; Kolla BP; Mansukhani MP; Netzel P; Frye MA
    Gen Hosp Psychiatry; 2012; 34(3):290-8. PubMed ID: 22305367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK; Gazioğlu S
    Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
    Vossler DG; Wilensky AJ; Cawthon DF; Kraemer DL; Ojemann LM; Caylor LM; Morgan JD
    Epilepsia; 2002 Feb; 43(2):154-9. PubMed ID: 11903461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alterations of the state of consciousness induced by valproic acid: 6 case reports].
    Campostrini R; Paganini M; Boncinelli L; Zaccara G; Arnetoli G; Zappoli R
    Riv Patol Nerv Ment; 1983; 104(1):23-34. PubMed ID: 6431599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
    Mehndiratta MM; Mehndiratta P; Phul P; Garg S
    J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encephalopathy and myoclonus triggered by valproic acid.
    Reif A; Leonhard C; Mössner R; Lesch KP; Fallgatter AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1061-3. PubMed ID: 15380868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid-induced hyperammonemic encephalopathy with triphasic waves.
    Kifune A; Kubota F; Shibata N; Akata T; Kikuchi S
    Epilepsia; 2000 Jul; 41(7):909-12. PubMed ID: 10897167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
    Tsai MF; Chen CY
    Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Valproate can induce reversible encephalopathy].
    Prakash S; Harbo T; Christensen J
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP; Ostergaard JR
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.